Cargando…
The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
Autores principales: | Szer, Jeff, Weisdorf, Daniel, Querol, Sergio, Foeken, Lydia, Madrigal, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091850/ https://www.ncbi.nlm.nih.gov/pubmed/32203269 http://dx.doi.org/10.1038/s41409-020-0873-x |
Ejemplares similares
-
“Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries”
por: Aljurf, Mahmoud, et al.
Publicado: (2019) -
COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020) -
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
por: Niederwieser, Dietger, et al.
Publicado: (2021) -
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation
por: Worel, Nina, et al.
Publicado: (2021) -
Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling
por: Anurathapan, Usanarat, et al.
Publicado: (2020)